| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Jie Sun | |
| Zhenning Wang | |||
| Yongxi Song | |||
| Zhonghua Wu | |||
| Jinxin Shi | |||
| Xi Zhong | |||
| Zhexu Guo | |||
| Cen Zhou | |||
| P2860 | cites work | Prognostic and clinical significance of VEGFR-3 in gastric cancer: A meta-analysis | Q49916935 |
| Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab. | Q52758014 | ||
| Prognostic role of C-reactive protein in gastric cancer: a meta-analysis. | Q54514438 | ||
| Risk Factors for Endometrial Cancer: An umbrella review of the literature | Q58616451 | ||
| Carcinoembryonic antigen in gastric juice as an aid in diagnosis of early gastric cancer | Q71431907 | ||
| Significance of serum and tissue carcinoembryonic antigen for the prognosis of gastric carcinoma patients | Q74199846 | ||
| Involvement of platelets in tumour angiogenesis? | Q77664605 | ||
| Cytology of peritoneal lavage performed during staging laparoscopy for gastrointestinal malignancies: is it useful? | Q77709620 | ||
| Gastric cancer | Q84276928 | ||
| The prognostic significance of p53 expression in gastric cancer: a meta-analysis | Q85790771 | ||
| Increased expression of MMP14 correlates with the poor prognosis of Chinese patients with gastric cancer | Q86883872 | ||
| Tumor-Educated Platelets as a Noninvasive Biomarker Source for Cancer Detection and Progression Monitoring | Q89157705 | ||
| Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients | Q90900489 | ||
| [Association of prognosis with insulin-like growth factor receptor type I expression in gastric cancer patients: a meta-analysis] | Q95459667 | ||
| The prognostic significance of pretreatment serum CEA levels in gastric cancer: a meta-analysis including 14651 patients | Q21131782 | ||
| An exploratory test for an excess of significant findings | Q24273224 | ||
| MUC1 Immunohistochemical Expression as a Prognostic Factor in Gastric Cancer: Meta-Analysis | Q26748809 | ||
| Can the Neutrophil to Lymphocyte Ratio Be Used to Determine Gastric Cancer Treatment Outcomes? A Systematic Review and Meta-Analysis | Q26765926 | ||
| Prognostic Value and Clinicopathological Significance of p-stat3 Among Gastric Carcinoma Patients: A Systematic Review and Meta-Analysis | Q26769034 | ||
| Free intraperitoneal tumor cells and outcome in gastric cancer patients: a systematic review and meta-analysis | Q26783309 | ||
| Correlation of cadherin-17 protein expression with clinicopathological features and prognosis of patients with sporadic gastric cancer | Q26783991 | ||
| Prognostic Value of FOXM1 in Patients with Malignant Solid Tumor: A Meta-Analysis and System Review | Q26785676 | ||
| Clinicopathologic and Prognostic Value of Serum Carbohydrate Antigen 19-9 in Gastric Cancer: A Meta-Analysis | Q26828549 | ||
| Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention | Q26849435 | ||
| Prognostic value of survivin in patients with gastric cancer: a systematic review with meta-analysis | Q27004677 | ||
| Prognostic significance of MET amplification and expression in gastric cancer: a systematic review with meta-analysis | Q27027981 | ||
| PD-L1 and Survival in Solid Tumors: A Meta-Analysis | Q28084090 | ||
| Biomarkers and surrogate endpoints: preferred definitions and conceptual framework | Q28203935 | ||
| Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer: A comprehensive meta-analysis with 4729 patients involved | Q30244324 | ||
| Hypoxia-inducible factor 1 alpha (HIF-1α) as a prognostic indicator in patients with gastric tumors: a meta-analysis | Q31134436 | ||
| Prognostic value of tumor-infiltrating FoxP3+ T cells in gastrointestinal cancers: a meta analysis | Q33609920 | ||
| Prognostic significance of ZEB1 and ZEB2 in digestive cancers: a cohort-based analysis and secondary analysis | Q33761782 | ||
| Prognostic significance of vascular endothelial growth factor expression in gastric carcinoma: a meta-analysis | Q34019881 | ||
| Abnormal β-catenin immunohistochemical expression as a prognostic factor in gastric cancer: a meta-analysis. | Q34168652 | ||
| Meta-analysis shows that circulating tumor cells including circulating microRNAs are useful to predict the survival of patients with gastric cancer | Q34410548 | ||
| Perineural invasion is an independent predictor of outcome in colorectal cancer. | Q34611646 | ||
| The cancer biomarker problem | Q34767213 | ||
| A personalized approach to cancer treatment: how biomarkers can help | Q34830939 | ||
| Poor prognosis of phosphatase of regenerating liver 3 expression in gastric cancer: a meta-analysis | Q35034895 | ||
| C-Met as a prognostic marker in gastric cancer: a systematic review and meta-analysis | Q35041171 | ||
| Sphingosine kinase 1 and cancer: a systematic review and meta-analysis | Q35108994 | ||
| Clinical and prognostic significance of HIF-1α, PTEN, CD44v6, and survivin for gastric cancer: a meta-analysis | Q35125058 | ||
| Abnormal FHIT protein expression may be correlated with poor prognosis in gastric cancer: a meta-analysis | Q35147072 | ||
| Prognostic and clinical significance of STAT3 and MMP9 in patients with gastric cancer: a meta-analysis of a Chinese cohort | Q35173525 | ||
| Circulating tumor cells (CTCs) detected by RT-PCR and its prognostic role in gastric cancer: a meta-analysis of published literature | Q35182266 | ||
| Meta-analysis: E-cadherin immunoexpression as a potential prognosis biomarker related to gastric cancer metastasis in Asian patients. | Q35333928 | ||
| Prognostic role of high Bmi-1 expression in Asian and Caucasian patients with solid tumors: a meta-analysis | Q35473103 | ||
| CD44 family proteins in gastric cancer: a meta-analysis and narrative review | Q35643626 | ||
| Prognostic and clinical significance of claudin-4 in gastric cancer: a meta-analysis | Q35673622 | ||
| The prognostic role of neutrophils to lymphocytes ratio and platelet count in gastric cancer: A meta-analysis | Q35726126 | ||
| High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability | Q35787046 | ||
| Paraneoplastic thrombocytosis in ovarian cancer. | Q35812402 | ||
| Prognostic Significance of Molecular Analysis of Peritoneal Fluid for Patients with Gastric Cancer: A Meta-Analysis | Q35961219 | ||
| Association of thymidylate synthase expression and clinical outcomes of gastric cancer patients treated with fluoropyrimidine-based chemotherapy: a meta-analysis | Q35972327 | ||
| Prognostic and clinical value of Sirt1 expression in gastric cancer: A systematic meta-analysis | Q35987933 | ||
| Prognostic value of Muc5AC in gastric cancer: A meta-analysis | Q36085609 | ||
| Prognostic Value of NME1 (NM23-H1) in Patients with Digestive System Neoplasms: A Systematic Review and Meta-Analysis | Q36102835 | ||
| HER3, but Not HER4, Plays an Essential Role in the Clinicopathology and Prognosis of Gastric Cancer: A Meta-Analysis | Q36106546 | ||
| Prognostic Value of Focal Adhesion Kinase (FAK) in Human Solid Carcinomas: A Meta-Analysis | Q36135842 | ||
| The Prognostic Role of the Platelet-Lymphocytes Ratio in Gastric Cancer: A Meta-Analysis | Q36147745 | ||
| Prognostic significance of tumor-associated macrophage infiltration in gastric cancer: a meta-analysis | Q36223168 | ||
| The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature | Q36317603 | ||
| p-Akt as a potential poor prognostic factor for gastric cancer: A systematic review and meta-analysis | Q36358262 | ||
| Prognostic significance of Cdx2 immunohistochemical expression in gastric cancer: a meta-analysis of published literatures | Q36498827 | ||
| Association of fascin-1 with mortality, disease progression and metastasis in carcinomas: a systematic review and meta-analysis | Q36793866 | ||
| Uncertainty in heterogeneity estimates in meta-analyses | Q36987539 | ||
| Prognostic role of STAT3 in solid tumors: a systematic review and meta-analysis | Q37190200 | ||
| Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges | Q37363395 | ||
| CD44v6: A metastasis-associated biomarker in patients with gastric cancer?: A comprehensive meta-analysis with heterogeneity analysis | Q37608369 | ||
| Prognostic significance of osteopontin expression in gastric cancer: a meta-analysis | Q37688419 | ||
| Predictive biomarkers: a paradigm shift towards personalized cancer medicine | Q37921593 | ||
| Prognostic value of vascular endothelial growth factor expression in resected gastric cancer | Q38045008 | ||
| Implementing personalized cancer genomics in clinical trials | Q38102920 | ||
| Prognostic role of human epidermal growth factor receptor in gastric cancer: a systematic review and meta-analysis | Q38122908 | ||
| The prognostic role of matrix metalloproteinase 2 in gastric cancer: a systematic review with meta-analysis | Q38194507 | ||
| The critical role of peritoneal cytology in the staging of gastric cancer: an evidence-based review | Q38213679 | ||
| Prognostic role of SPARC expression in gastric cancer: a meta-analysis | Q38268097 | ||
| Prognostic value of SOX2 in digestive tumors: a meta-analysis | Q38273013 | ||
| The prognostic role of Leucine-rich repeat-containing G-protein-coupled receptor 5 in gastric cancer: A systematic review with meta-analysis | Q38386675 | ||
| Role of EZH2 protein expression in gastric carcinogenesis among Asians: a meta-analysis | Q38398580 | ||
| Estimates of cancer incidence and mortality in China, 2013 | Q38619604 | ||
| PD-L1 and gastric cancer prognosis: A systematic review and meta-analysis. | Q38630412 | ||
| Prognostic role of fibroblast growth factor receptor 2 in human solid tumors: A systematic review and meta-analysis | Q38723818 | ||
| The urokinase plasminogen activation system in gastroesophageal cancer: A systematic review and meta-analysis. | Q38833520 | ||
| Global estimates of cancer prevalence for 27 sites in the adult population in 2008. | Q38920305 | ||
| Detection value of free cancer cells in peritoneal washing in gastric cancer: a systematic review and meta-analysis | Q39079745 | ||
| Meta-Analysis of the Relationship between NM23 Expression to Gastric Cancer Risk and Clinical Features. | Q39236583 | ||
| Clinicopathologic significance and prognostic value of Ki-67 expression in patients with gastric cancer: a meta-analysis | Q39295168 | ||
| Randomized controlled trial of screening for hepatocellular carcinoma | Q39679685 | ||
| Prognostic Significance of Dickkopf-1 in Gastric Cancer Survival: A Meta-Analysis | Q39881848 | ||
| Expression of chemokine receptor CCR7 is a negative prognostic factor for patients with gastric cancer: a meta-analysis | Q40849688 | ||
| Prognostic impact of preoperative NLR and CA19-9 in pancreatic cancer | Q40925321 | ||
| C-erbB-2 expression and prognosis of gastric cancer: a meta-analysis | Q41082530 | ||
| Prognostic value of excision repair cross-complementation group 1 expression in gastric cancer: A meta-analysis | Q41205616 | ||
| Clinicopathological and prognostic significance of Ki-67 immunohistochemical expression in gastric cancer: a systematic review and meta-analysis | Q41499284 | ||
| S100A4 expression and prognosis of gastric cancer: a meta-analysis | Q41686163 | ||
| The prognostic significance of HOTAIR for predicting clinical outcome in patients with digestive system tumors | Q41742058 | ||
| Tumor-infiltrating immune cells and prognosis in gastric cancer: a systematic review and meta-analysis | Q41763532 | ||
| Unique characteristics of ARID1A mutation and protein level in gastric and colorectal cancer: A meta-analysis | Q42050401 | ||
| Heterogeneous views on heterogeneity | Q43079361 | ||
| Prognostic significance of HER2 expression based on trastuzumab for gastric cancer (ToGA) criteria in gastric cancer: an updated meta-analysis | Q43479667 | ||
| Interpretation of random effects meta-analyses. | Q43810883 | ||
| Synthesis of observational studies should consider credibility ceilings | Q44110304 | ||
| Screening for liver cancer: results of a randomised controlled trial in Qidong, China | Q45107131 | ||
| Matrix metalloproteinase-9 as a prognostic factor in gastric cancer: a meta-analysis. | Q45776083 | ||
| VEGF-C expression is associated with the poor survival in gastric cancer tissue | Q45802652 | ||
| Physical activity and cancer: an umbrella review of the literature including 22 major anatomical sites and 770 000 cancer cases | Q46676430 | ||
| Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis | Q47581817 | ||
| AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both | Q47684085 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 1321 | |
| P577 | publication date | 2019-11-29 | |
| P1433 | published in | Frontiers in Oncology | Q26839986 |
| P1476 | title | Prognostic Biomarkers for Gastric Cancer: An Umbrella Review of the Evidence | |
| P478 | volume | 9 |
Search more.